Showing results (111-120 of 463) with videos related to
Sort By:
Pageof 47
Clinical Pharmacology and Therapeutics|April 25, 2022
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical FactorsSpinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.Pharmacogenetics and Genomics|November 10, 2009
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin responseMatthijs L Becker, Loes E Visser, Ron H N van Schaik, et al.BMC Nephrology|December 11, 2013
Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patientsHilde R H de Geus, Gijs Fortrie, Michiel G H Betjes, et al.European Journal of Neurology|October 2, 2019
Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot studyM E Adrichem, S R Bus, L Wieske, et al.Clinical Pharmacology and Therapeutics|February 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the ModelSpinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.Therapeutic Drug Monitoring|May 14, 2011
CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearanceNilufar Pashaee, Rachida Bouamar, Dennis A Hesselink, et al.Clinical Chemistry and Laboratory Medicine|October 26, 2010
Nucleic acid reference materials (NARMs): definitions and issuesDeborah A Payne, Cyril D S Mamotte, David Gancberg, et al.Pharmacoepidemiology and Drug Safety|October 6, 2009
Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapyMatthijs L Becker, Loes E Visser, Ron H N van Schaik, et al.Molecular Genetics and Metabolism|April 14, 2012
Small fiber neuropathy in Fabry diseaseMarieke Biegstraaten, Carla E M Hollak, Mayienne Bakkers, et al.Journal of Neurology|January 13, 2005
Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy IaCamiel Verhamme, Ivo N van Schaik, Johannes H T M Koelman, et al.Pageof 47